TY - JOUR
T1 - Post-traumatic hypoxia is associated with prolonged cerebral cytokine production, higher serum biomarker levels, and poor outcome in patients with severe traumatic brain injury
AU - Yan, Edwin Bingbing
AU - Satgunaseelan, Laveniya
AU - Paul, Eldho
AU - Bye, Nicole
AU - Nguyen, Phuong
AU - Agyapomaa, Doreen
AU - Kossmann, Thomas K
AU - Rosenfeld, Jeffrey Victor
AU - Morganti-Kossmann, Maria Cristina
PY - 2014
Y1 - 2014
N2 - Secondary hypoxia is a known contributor to adverse outcomes in patients with traumatic brain injury (TBI). Based on the
evidence that hypoxia and TBI in isolation induce neuroinflammation, we investigated whether TBI combined with
hypoxia enhances cerebral cytokine production. We also explored whether increased concentrations of injury biomarkers
discriminate between hypoxic (Hx) and normoxic (Nx) patients, correlate to worse outcome, and depend on blood?brain
barrier (BBB) dysfunction. Forty-two TBI patients with Glasgow Coma Scale 8 were recruited. Cerebrospinal fluid
(CSF) and serum were collected over 6 days. Patients were divided into Hx (n = 22) and Nx (n = 20) groups. Eight
cytokines were measured in the CSF; albumin, S100, myelin basic protein (MBP) and neuronal specific enolase (NSE)
were quantified in serum. CSF/serum albumin quotient was calculated for BBB function. Glasgow Outcome Scale
Extended (GOSE) was assessed at 6 months post-TBI. Production of granulocye macrophage-colony stimulating factor
(GM-CSF) was higher, and profiles of GM-CSF, interferon (IFN)-c and, to a lesser extent, tumor necrosis factor (TNF),
were prolonged in the CSF of Hx but not Nx patients at 4?5 days post-TBI. Interleukin (IL)-2, IL-4, IL-6, and IL-10
increased similarly in both Hx and Nx groups. S100, MBP, and NSE were significantly higher in Hx patients with
unfavorable outcome. Among these three biomarkers, S100 showed the strongest correlations to GOSE after TBI-Hx.
Elevated CSF/serum albumin quotients lasted for 5 days post-TBI and displayed similar profiles in Hx and Nx patients.
We demonstrate for the first time that post-TBI hypoxia is associated with prolonged neuroinflammation, amplified
extravasation of biomarkers, and poor outcome. S100 and MBP could be implemented to track the occurrence of post-TBI
hypoxia, and prompt adequate treatment.
AB - Secondary hypoxia is a known contributor to adverse outcomes in patients with traumatic brain injury (TBI). Based on the
evidence that hypoxia and TBI in isolation induce neuroinflammation, we investigated whether TBI combined with
hypoxia enhances cerebral cytokine production. We also explored whether increased concentrations of injury biomarkers
discriminate between hypoxic (Hx) and normoxic (Nx) patients, correlate to worse outcome, and depend on blood?brain
barrier (BBB) dysfunction. Forty-two TBI patients with Glasgow Coma Scale 8 were recruited. Cerebrospinal fluid
(CSF) and serum were collected over 6 days. Patients were divided into Hx (n = 22) and Nx (n = 20) groups. Eight
cytokines were measured in the CSF; albumin, S100, myelin basic protein (MBP) and neuronal specific enolase (NSE)
were quantified in serum. CSF/serum albumin quotient was calculated for BBB function. Glasgow Outcome Scale
Extended (GOSE) was assessed at 6 months post-TBI. Production of granulocye macrophage-colony stimulating factor
(GM-CSF) was higher, and profiles of GM-CSF, interferon (IFN)-c and, to a lesser extent, tumor necrosis factor (TNF),
were prolonged in the CSF of Hx but not Nx patients at 4?5 days post-TBI. Interleukin (IL)-2, IL-4, IL-6, and IL-10
increased similarly in both Hx and Nx groups. S100, MBP, and NSE were significantly higher in Hx patients with
unfavorable outcome. Among these three biomarkers, S100 showed the strongest correlations to GOSE after TBI-Hx.
Elevated CSF/serum albumin quotients lasted for 5 days post-TBI and displayed similar profiles in Hx and Nx patients.
We demonstrate for the first time that post-TBI hypoxia is associated with prolonged neuroinflammation, amplified
extravasation of biomarkers, and poor outcome. S100 and MBP could be implemented to track the occurrence of post-TBI
hypoxia, and prompt adequate treatment.
UR - http://online.liebertpub.com/doi/pdf/10.1089/neu.2013.3087
U2 - 10.1089/neu.2013.3087
DO - 10.1089/neu.2013.3087
M3 - Article
SN - 0897-7151
VL - 31
SP - 618
EP - 629
JO - Journal of Neurotrauma
JF - Journal of Neurotrauma
IS - 7
ER -